EDAP-TMS_RGB-300dpi-20160111.png
EDAP Announces Scientific Presentation at 2024 AAGL Global Congress Comparing Focal One HIFU Versus Surgery for the Treatment of Deep Infiltrating Endometriosis
November 19, 2024 08:00 ET | EDAP TMS S.A.
           Treatment with robotic HIFU showed reduction in moderate and severe post-operative complications and reduced hospital stay compared to surgery LYON, France, November 19, 2024 - EDAP TMS...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP Reports Third Quarter 2024 Financial Results
November 07, 2024 07:00 ET | EDAP TMS S.A.
         Reported Q3 worldwide revenue of EUR 13.1 million (USD 14.4 million), increasing 11.6% over Q3 2023Reported Q3 worldwide HIFU revenue of EUR 4.5 million (USD 4.9 million), increasing 48.2%...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP to Participate in the 2024 Jefferies London Healthcare Conference
November 06, 2024 08:00 ET | EDAP TMS S.A.
          LYON, France, November 6, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced that Ryan Rhodes, Chief Executive Officer, is scheduled to...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP to Announce Third Quarter 2024 Financial Results on November 7, 2024
October 24, 2024 08:00 ET | EDAP TMS S.A.
Company to host conference call and webcast on Thursday, November 7th at 8:30am EDT LYON, France, October 24, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP Announces First Patients Treated in Phase I/II Study Evaluating Focal One Robotic HIFU for the Treatment of Benign Prostatic Hyperplasia (BPH)
October 01, 2024 07:00 ET | EDAP TMS S.A.
         LYON, France, October 1, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first patients have been treated in a Phase I/II...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP and Avenda Health Launch World’s First AI-Assisted Focal One® Robotic HIFU Procedures
September 19, 2024 08:00 ET | EDAP TMS S.A.
                                                 First Unfold AI®-Assisted Focal One procedures successfully performed at the UCLA School of MedicineFDA-cleared Unfold AI enables urologists to...
SCBC_BLK_RD.png
SoCalBio’s 26th Annual Two-Day Investor Partnership Conference hosted at the Hyatt Regency Newport Beach for the Medical Device and Biotechnology Industry
September 18, 2024 13:14 ET | Southern California Biomedical Council
The Southern California Biomedical Council announced the full lineup of speakers and presenting companies for its 26th Annual SoCalBio Investor Conference.
EDAP-TMS_RGB-300dpi-20160111.png
EDAP to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
August 29, 2024 08:00 ET | EDAP TMS S.A.
         LYON, France, August 29, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced that Ryan Rhodes, Chief Executive Officer, is scheduled to...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP Reports Second Quarter 2024 Financial Results
August 28, 2024 07:00 ET | EDAP TMS S.A.
        Record Q2 2024 total worldwide revenue of EUR 15.8 million (USD 17.0 million) increased 10.6% over Q2 2023Record first half 2024 total worldwide revenue of EUR 30.7 million (USD...
NBME’s Fee Assistanc
NBME’s Fee Assistance program for USMLE supports medical students with financial need
August 26, 2024 11:51 ET | NBME
PHILADELPHIA, Aug. 26, 2024 (GLOBE NEWSWIRE) -- NBME is committed to supporting learners with programs and resources that make the path to medical education more accessible and equitable. The...